Last reviewed · How we verify

NCT06685393: PRP-IPRF

Efficacy of Injectable Platelet-rich Fibrin Versus Platelet-Rich Plasma As Adjunctive to Scaling and Root Planning in Non-surgical Periodontal Therapy of Periodontitis Patients

Completed NA Last updated 12 November 2024
What this trial tests

NA trial testing Platelet rich plasma (PRP) in Peridontal Disease in 40 participants. Completed in 25 March 2024.

Timeline
5 January 2023
Primary endpoint
20 December 2023
25 March 2024

Quick facts

Lead sponsorELsabbahy Ahmed Mohamed Youssef
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date5 January 2023
Primary completion20 December 2023
Estimated completion25 March 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

ELsabbahy Ahmed Mohamed Youssef

Who can join

Adults 25 to 45, any sex, with Peridontal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the Efficacy of Injectable Platelet-rich Fibrin versus Platelet-Rich Plasma as adjunctive to scaling and root planning in non-surgical periodontal therapy of Periodontitis patients (Randomized controlled clinical trial)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Platelet rich plasma (PRP)

Trials testing the same drug.

Other recruiting trials for Peridontal Disease

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06685393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing